Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 391

1.

Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment.

Stiekema LCA, Stroes ESG, Verweij SL, Kassahun H, Chen L, Wasserman SM, Sabatine MS, Mani V, Fayad ZA.

Eur Heart J. 2018 Dec 18. doi: 10.1093/eurheartj/ehy862. [Epub ahead of print]

PMID:
30561610
2.

Correction of respiratory and cardiac motion in cardiac PET/MR using MR-based motion modeling.

Robson PM, Trivieri M, Karakatsanis NA, Padilla M, Abgral R, Dweck MR, Kovacic JC, Fayad ZA.

Phys Med Biol. 2018 Nov 14;63(22):225011. doi: 10.1088/1361-6560/aaea97.

PMID:
30426968
3.

Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance.

Braza MS, van Leent MMT, Lameijer M, Sanchez-Gaytan BL, Arts RJW, Pérez-Medina C, Conde P, Garcia MR, Gonzalez-Perez M, Brahmachary M, Fay F, Kluza E, Kossatz S, Dress RJ, Salem F, Rialdi A, Reiner T, Boros P, Strijkers GJ, Calcagno CC, Ginhoux F, Marazzi I, Lutgens E, Nicolaes GAF, Weber C, Swirski FK, Nahrendorf M, Fisher EA, Duivenvoorden R, Fayad ZA, Netea MG, Mulder WJM, Ochando J.

Immunity. 2018 Nov 20;49(5):819-828.e6. doi: 10.1016/j.immuni.2018.09.008. Epub 2018 Nov 6.

PMID:
30413362
4.

Reproducibility of thrombus volume quantification in multicenter computed tomography pulmonary angiography studies.

Kaufman AE, Pruzan AN, Hsu C, Ramachandran S, Jacobi A, Patel I, Schwocho L, Mercuri MF, Fayad ZA, Mani V.

World J Radiol. 2018 Oct 28;10(10):124-134. doi: 10.4329/wjr.v10.i10.124.

5.

Amygdalar Metabolic Activity Independently Associates With Progression of Visceral Adiposity.

Ishai A, Osborne MT, Tung B, Wang Y, Hammad B, Patrich T, Oberfeld B, Fayad ZA, Giles JT, Lo J, Shin LM, Grinspoon SK, Koenen KC, Pitman RK, Tawakol A.

J Clin Endocrinol Metab. 2019 Apr 1;104(4):1029-1038. doi: 10.1210/jc.2018-01456.

PMID:
30383236
6.

Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life.

Robinson JG, Williams KJ, Gidding S, Borén J, Tabas I, Fisher EA, Packard C, Pencina M, Fayad ZA, Mani V, Rye KA, Nordestgaard BG, Tybjærg-Hansen A, Douglas PS, Nicholls SJ, Pagidipati N, Sniderman A.

J Am Heart Assoc. 2018 Oct 16;7(20):e009778. doi: 10.1161/JAHA.118.009778. No abstract available.

7.

Monocyte and Macrophage Dynamics in the Cardiovascular System: JACC Macrophage in CVD Series (Part 3).

Fayad ZA, Swirski FK, Calcagno C, Robbins CS, Mulder W, Kovacic JC.

J Am Coll Cardiol. 2018 Oct 30;72(18):2198-2212. doi: 10.1016/j.jacc.2018.08.2150. Review.

PMID:
30360828
8.

Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis.

Senders ML, Hernot S, Carlucci G, van de Voort JC, Fay F, Calcagno C, Tang J, Alaarg A, Zhao Y, Ishino S, Palmisano A, Boeykens G, Meerwaldt AE, Sanchez-Gaytan BL, Baxter S, Zendman L, Lobatto ME, Karakatsanis NA, Robson PM, Broisat A, Raes G, Lewis JS, Tsimikas S, Reiner T, Fayad ZA, Devoogdt N, Mulder WJM, Pérez-Medina C.

JACC Cardiovasc Imaging. 2018 Oct 12. pii: S1936-878X(18)30753-8. doi: 10.1016/j.jcmg.2018.07.027. [Epub ahead of print]

9.

Amygdalar activity predicts future incident diabetes independently of adiposity.

Osborne MT, Ishai A, Hammad B, Tung B, Wang Y, Baruch A, Fayad ZA, Giles JT, Lo J, Shin LM, Grinspoon SK, Koenen KC, Pitman RK, Tawakol A.

Psychoneuroendocrinology. 2019 Feb;100:32-40. doi: 10.1016/j.psyneuen.2018.09.024. Epub 2018 Sep 22.

PMID:
30273797
10.

Nanoimmunotherapy to treat ischaemic heart disease.

Duivenvoorden R, Senders ML, van Leent MMT, Pérez-Medina C, Nahrendorf M, Fayad ZA, Mulder WJM.

Nat Rev Cardiol. 2019 Jan;16(1):21-32. doi: 10.1038/s41569-018-0073-1. Review.

PMID:
30209355
11.

Development and Multiparametric Evaluation of Experimental Atherosclerosis in Rabbits.

Senders ML, Lobatto ME, Soler R, Lairez O, Pérez-Medina C, Calcagno C, Fayad ZA, Mulder WJM, Fay F.

Methods Mol Biol. 2018;1816:385-400. doi: 10.1007/978-1-4939-8597-5_30.

PMID:
29987836
12.

New methods to image unstable atherosclerotic plaques.

Andrews JPM, Fayad ZA, Dweck MR.

Atherosclerosis. 2018 May;272:118-128. doi: 10.1016/j.atherosclerosis.2018.03.021. Epub 2018 Mar 14. Review.

13.

Effect of varying computed tomography acquisition and reconstruction parameters on semi-automated clot volume quantification.

Kaufman AE, Pruzan AN, Hsu C, Ramachandran S, Jacobi A, Fayad ZA, Mani V.

World J Radiol. 2018 Mar 28;10(3):24-29. doi: 10.4329/wjr.v10.i3.24.

14.

Carotid Artery Remodeling Is Segment Specific: An In Vivo Study by Vessel Wall Magnetic Resonance Imaging.

Watase H, Sun J, Hippe DS, Balu N, Li F, Zhao X, Mani V, Fayad ZA, Fuster V, Hatsukami TS, Yuan C.

Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):927-934. doi: 10.1161/ATVBAHA.117.310296. Epub 2018 Feb 22.

PMID:
29472231
15.

Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor.

Calcagno C, Lairez O, Hawkins J, Kerr SW, Dugas MS, Simpson T, Epskamp J, Robson PM, Eldib M, Bander I, K-Raman P, Ramachandran S, Pruzan A, Kaufman A, Mani V, Ehlgen A, Niessen HG, Broadwater J, Fayad ZA.

JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 2):291-301. doi: 10.1016/j.jcmg.2017.11.030.

16.

PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis.

Senders ML, Que X, Cho YS, Yeang C, Groenen H, Fay F, Calcagno C, Meerwaldt AE, Green S, Miu P, Lobatto ME, Reiner T, Fayad ZA, Witztum JL, Mulder WJM, Pérez-Medina C, Tsimikas S.

J Am Coll Cardiol. 2018 Jan 23;71(3):321-335. doi: 10.1016/j.jacc.2017.11.036.

17.

High-Density Lipoprotein Nanobiologics for Precision Medicine.

Mulder WJM, van Leent MMT, Lameijer M, Fisher EA, Fayad ZA, Pérez-Medina C.

Acc Chem Res. 2018 Jan 16;51(1):127-137. doi: 10.1021/acs.accounts.7b00339. Epub 2017 Dec 27.

PMID:
29281244
18.

Social stress induces neurovascular pathology promoting depression.

Menard C, Pfau ML, Hodes GE, Kana V, Wang VX, Bouchard S, Takahashi A, Flanigan ME, Aleyasin H, LeClair KB, Janssen WG, Labonté B, Parise EM, Lorsch ZS, Golden SA, Heshmati M, Tamminga C, Turecki G, Campbell M, Fayad ZA, Tang CY, Merad M, Russo SJ.

Nat Neurosci. 2017 Dec;20(12):1752-1760. doi: 10.1038/s41593-017-0010-3. Epub 2017 Nov 13.

19.

Cardiovascular Immunotherapy and the Role of Imaging.

Zupančič E, Fayad ZA, Mulder WJM.

Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):e167-e171. doi: 10.1161/ATVBAHA.117.309227. Review. No abstract available.

20.

Integrating nanomedicine and imaging.

Pérez-Medina C, Hak S, Reiner T, Fayad ZA, Nahrendorf M, Mulder WJM.

Philos Trans A Math Phys Eng Sci. 2017 Nov 28;375(2107). pii: 20170110. doi: 10.1098/rsta.2017.0110. Review.

21.

Arterial Thrombus Stability: Does It Matter and Can We Detect It?

Gorog DA, Fayad ZA, Fuster V.

J Am Coll Cardiol. 2017 Oct 17;70(16):2036-2047. doi: 10.1016/j.jacc.2017.08.065. Review.

22.

MR/PET Imaging of the Cardiovascular System.

Robson PM, Dey D, Newby DE, Berman D, Li D, Fayad ZA, Dweck MR.

JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt A):1165-1179. doi: 10.1016/j.jcmg.2017.07.008. Review.

23.

Unraveling Vascular Inflammation: From Immunology to Imaging.

Teague HL, Ahlman MA, Alavi A, Wagner DD, Lichtman AH, Nahrendorf M, Swirski FK, Nestle F, Gelfand JM, Kaplan MJ, Grinspoon S, Ridker PM, Newby DE, Tawakol A, Fayad ZA, Mehta NN.

J Am Coll Cardiol. 2017 Sep 12;70(11):1403-1412. doi: 10.1016/j.jacc.2017.07.750. Review.

24.

Imaging: Perivascular fat - an unheralded informant of coronary inflammation.

Dweck MR, Fayad ZA.

Nat Rev Cardiol. 2017 Oct;14(10):573-574. doi: 10.1038/nrcardio.2017.127. Epub 2017 Aug 24. No abstract available.

PMID:
28836621
25.

Vessel wall characterization using quantitative MRI: what's in a number?

Coolen BF, Calcagno C, van Ooij P, Fayad ZA, Strijkers GJ, Nederveen AJ.

MAGMA. 2018 Feb;31(1):201-222. doi: 10.1007/s10334-017-0644-x. Epub 2017 Aug 14. Review.

26.

Reply to: "β-blocker treatment of vascular disease in cocaine addiction".

Bachi K, Mani V, Trivieri MG, Jeyachandran D, Fayad ZA, Goldstein RZ, Alia-Klein N.

Atherosclerosis. 2017 Sep;264:123-124. doi: 10.1016/j.atherosclerosis.2017.07.012. Epub 2017 Jul 15. No abstract available.

PMID:
28735812
27.

A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis.

Alaarg A, Senders ML, Varela-Moreira A, Pérez-Medina C, Zhao Y, Tang J, Fay F, Reiner T, Fayad ZA, Hennink WE, Metselaar JM, Mulder WJM, Storm G.

J Control Release. 2017 Sep 28;262:47-57. doi: 10.1016/j.jconrel.2017.07.013. Epub 2017 Jul 9.

28.

Plaque microvascularization and permeability: Key players in atherogenesis and plaque rupture.

Calcagno C, Fayad ZA, Raggi P.

Atherosclerosis. 2017 Aug;263:320-321. doi: 10.1016/j.atherosclerosis.2017.06.915. Epub 2017 Jun 21. No abstract available.

PMID:
28673479
29.

3D black blood MR angiography of the carotid arteries. A simple sequence for plaque hemorrhage and stenosis evaluation.

Sigovan M, Bidet C, Bros S, Boussel L, Mechtouff L, Robson PM, Fayad ZA, Millon A, Douek P.

Magn Reson Imaging. 2017 Oct;42:95-100. doi: 10.1016/j.mri.2017.06.004. Epub 2017 Jun 16.

30.

Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.

Dweck MR, Abgral R, Trivieri MG, Robson PM, Karakatsanis N, Mani V, Palmisano A, Miller MA, Lala A, Chang HL, Sanz J, Contreras J, Narula J, Fuster V, Padilla M, Fayad ZA, Kovacic JC.

JACC Cardiovasc Imaging. 2018 Jan;11(1):94-107. doi: 10.1016/j.jcmg.2017.02.021. Epub 2017 Jun 14.

31.

Applying nanomedicine in maladaptive inflammation and angiogenesis.

Alaarg A, Pérez-Medina C, Metselaar JM, Nahrendorf M, Fayad ZA, Storm G, Mulder WJM.

Adv Drug Deliv Rev. 2017 Sep 15;119:143-158. doi: 10.1016/j.addr.2017.05.009. Epub 2017 May 12. Review.

32.

Intraplaque and Cellular Distribution of Dextran-Coated Iron Oxide Fluorescently Labeled Nanoparticles: Insights Into Atherothrombosis and Plaque Rupture.

Calcagno C, Fayad ZA.

Circ Cardiovasc Imaging. 2017 May;10(5). pii: e006533. doi: 10.1161/CIRCIMAGING.117.006533. No abstract available.

33.

Multitarget Vulnerable Plaque Imaging.

Dweck MR, Fayad ZA.

Circ Cardiovasc Imaging. 2017 May;10(5). pii: e006491. doi: 10.1161/CIRCIMAGING.117.006491. No abstract available.

34.

Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis.

Beldman TJ, Senders ML, Alaarg A, Pérez-Medina C, Tang J, Zhao Y, Fay F, Deichmöller J, Born B, Desclos E, van der Wel NN, Hoebe RA, Kohen F, Kartvelishvily E, Neeman M, Reiner T, Calcagno C, Fayad ZA, de Winther MPJ, Lutgens E, Mulder WJM, Kluza E.

ACS Nano. 2017 Jun 27;11(6):5785-5799. doi: 10.1021/acsnano.7b01385. Epub 2017 May 15.

35.

Rationale and Design of Family-Based Approach in a Minority Community Integrating Systems-Biology for Promotion of Health (FAMILIA).

Bansilal S, Vedanthan R, Kovacic JC, Soto AV, Latina J, Björkegren JLM, Jaslow R, Santana M, Sartori S, Giannarelli C, Mani V, Hajjar R, Schadt E, Kasarskis A, Fayad ZA, Fuster V.

Am Heart J. 2017 May;187:170-181. doi: 10.1016/j.ahj.2017.02.020. Epub 2017 Feb 22.

36.

Vascular disease in cocaine addiction.

Bachi K, Mani V, Jeyachandran D, Fayad ZA, Goldstein RZ, Alia-Klein N.

Atherosclerosis. 2017 Jul;262:154-162. doi: 10.1016/j.atherosclerosis.2017.03.019. Epub 2017 Mar 14. Review.

37.

Investigating the Cellular Specificity in Tumors of a Surface-Converting Nanoparticle by Multimodal Imaging.

Fay F, Hansen L, Hectors SJCG, Sanchez-Gaytan BL, Zhao Y, Tang J, Munitz J, Alaarg A, Braza MS, Gianella A, Aaronson SA, Reiner T, Kjems J, Langer R, Hoeben FJM, Janssen HM, Calcagno C, Strijkers GJ, Fayad ZA, Pérez-Medina C, Mulder WJM.

Bioconjug Chem. 2017 May 17;28(5):1413-1421. doi: 10.1021/acs.bioconjchem.7b00086. Epub 2017 May 5.

38.

Feasibility of imaging superficial palmar arch using micro-ultrasound, 7T and 3T magnetic resonance imaging.

Pruzan AN, Kaufman AE, Calcagno C, Zhou Y, Fayad ZA, Mani V.

World J Radiol. 2017 Feb 28;9(2):79-84. doi: 10.4329/wjr.v9.i2.79.

39.

Molecular Imaging of Atheroma: Deciphering How and When to Use 18F-Sodium Fluoride and 18F-Fluorodeoxyglucose.

Tawakol A, Osborne MT, Fayad ZA.

Circ Cardiovasc Imaging. 2017 Mar;10(3). pii: e006183. doi: 10.1161/CIRCIMAGING.117.006183. No abstract available.

40.

Real-Time Monitoring of Nanoparticle Formation by FRET Imaging.

Sanchez-Gaytan BL, Fay F, Hak S, Alaarg A, Fayad ZA, Pérez-Medina C, Mulder WJ, Zhao Y.

Angew Chem Int Ed Engl. 2017 Mar 6;56(11):2923-2926. doi: 10.1002/anie.201611288. Epub 2017 Jan 23.

41.

Coronary Artery PET/MR Imaging: Feasibility, Limitations, and Solutions.

Robson PM, Dweck MR, Trivieri MG, Abgral R, Karakatsanis NA, Contreras J, Gidwani U, Narula JP, Fuster V, Kovacic JC, Fayad ZA.

JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt A):1103-1112. doi: 10.1016/j.jcmg.2016.09.029. Epub 2017 Jan 18.

42.

Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease.

Keliher EJ, Ye YX, Wojtkiewicz GR, Aguirre AD, Tricot B, Senders ML, Groenen H, Fay F, Perez-Medina C, Calcagno C, Carlucci G, Reiner T, Sun Y, Courties G, Iwamoto Y, Kim HY, Wang C, Chen JW, Swirski FK, Wey HY, Hooker J, Fayad ZA, Mulder WJ, Weissleder R, Nahrendorf M.

Nat Commun. 2017 Jan 16;8:14064. doi: 10.1038/ncomms14064.

43.

Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study.

Tawakol A, Ishai A, Takx RA, Figueroa AL, Ali A, Kaiser Y, Truong QA, Solomon CJ, Calcagno C, Mani V, Tang CY, Mulder WJ, Murrough JW, Hoffmann U, Nahrendorf M, Shin LM, Fayad ZA, Pitman RK.

Lancet. 2017 Feb 25;389(10071):834-845. doi: 10.1016/S0140-6736(16)31714-7. Epub 2017 Jan 12. Erratum in: Lancet. 2017 Feb 25;389(10071):804. Lancet. 2017 Feb 25;389(10071):804.

PMID:
28088338
44.

18F-Sodium Fluoride PET/MR for the Assessment of Cardiac Amyloidosis.

Trivieri MG, Dweck MR, Abgral R, Robson PM, Karakatsanis NA, Lala A, Contreras J, Sahni G, Gopalan R, Gorevic P, Fuster V, Narula J, Fayad ZA.

J Am Coll Cardiol. 2016 Dec 20;68(24):2712-2714. doi: 10.1016/j.jacc.2016.09.953. No abstract available.

45.

Coronary Plaque Morphology and the Anti-Inflammatory Impact of Atorvastatin: A Multicenter 18F-Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Study.

Singh P, Emami H, Subramanian S, Maurovich-Horvat P, Marincheva-Savcheva G, Medina HM, Abdelbaky A, Alon A, Shankar SS, Rudd JH, Fayad ZA, Hoffmann U, Tawakol A.

Circ Cardiovasc Imaging. 2016 Dec;9(12). pii: e004195.

46.

Imaging the Permeable Endothelium: Predicting Plaque Rupture in Atherosclerotic Rabbits.

Calcagno C, Fayad ZA.

Circ Cardiovasc Imaging. 2016 Dec;9(12). pii: e005955. No abstract available.

47.

Imaging-guided revival of nanomedicine?

Senders ML, Fayad ZA, Reiner T, Mulder WJ, Pérez-Medina C.

Nanomedicine (Lond). 2017 Jan;12(2):89-90. Epub 2016 Nov 23. No abstract available.

48.

Computed Tomography and Cardiac Magnetic Resonance in Ischemic Heart Disease.

Dweck MR, Williams MC, Moss AJ, Newby DE, Fayad ZA.

J Am Coll Cardiol. 2016 Nov 15;68(20):2201-2216. doi: 10.1016/j.jacc.2016.08.047. Review.

49.

Cap inflammation leads to higher plaque cap strain and lower cap stress: An MRI-PET/CT-based FSI modeling approach.

Tang D, Yang C, Huang S, Mani V, Zheng J, Woodard PK, Robson P, Teng Z, Dweck M, Fayad ZA.

J Biomech. 2017 Jan 4;50:121-129. doi: 10.1016/j.jbiomech.2016.11.011. Epub 2016 Nov 11.

50.

The future of imaging in cardiovascular disease intervention trials: 2017 and beyond.

Doris MK, Dweck MR, Fayad ZA.

Curr Opin Lipidol. 2016 Dec;27(6):605-614. Review.

Supplemental Content

Loading ...
Support Center